David Yang
Head of China Private Equity @ Abu Dhabi Investment Authority
David Yang is a Series A investor at Abu Dhabi Investment Authority focused on Life Science and Biotechnology. David Yang has over 10 years of experience in healthcare. Prior to joining Essex Woodlands, Mr. Yang was a Principal with Warburg Pincus in China where he was a key member of their healthcare team since 2007. He worked particularly closely with Warburg Pincus investments in Lepu Medical, and CITIC Pharmaceuticals.Prior to joining WarburgPincus, he worked at Morgan Stanley and Fidelity Investments in the US, and with McKinsey & Co. in Shanghai. Mr. Yang obtained an MBA from Columbia Business School. Mr Yang joined Essex Woodlands as Managing Director and co-head of the Shanghai office in April 2012.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries David Yang invests in
Stages David Yang invests in
Countries David Yang invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Atrandi Biosciences
|
Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preservingsingle-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries. | $25M / Series A / Feb 18, 2025 |
Co-Investors
About Abu Dhabi Investment Authority
Abu Dhabi Investment Authority is an investment management agency investing funds on behalf of the Government of Abu Dhabi. ADIA does not directly to manage or take an operational role in the companies in which it invests but through it's PPP Representative Eiosoft Capital Group LLC.
Abu Dhabi Investment Authority Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Kripke
Director, Portfolio Manager - US Team
|
|||
|
David Yang
Head of China Private Equity
|
|||
Han Huang
Investment Risk Manager
|
|||
Jan Schuster
Portfolio Manager - Private Equity Division
|
|||
Jeroen Verleun
Investment Manager External Fixed Income
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Yang invest in?
David Yang invests primarily in Life Science, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Lithuania. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did David Yang last invest?
The most recent investment recorded for David Yang closed in Feb 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
